Results 151 to 160 of about 16,602 (194)
Some of the next articles are maybe not open access.
Therapeutic Efficacy of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Journal of Computer Assisted Tomography, 1995Our goal was to evaluate the usefulness of multisection dynamic MRI with gadopentetate dimeglumine in the assessment of the therapeutic efficacy of transcatheter arterial chemoembolization (TAE) with iodized oil for hepatocellular carcinomas (HCCs).Findings on multisection dynamic MRI images were compared with gross appearance and histologic findings ...
K, Ito +7 more
openaire +2 more sources
Journal of Computer Assisted Tomography, 2012
Computed tomographic (CT) perfusion imaging has been applied in many clinical areas, but few studies have addressed the values of CT perfusion imaging in evaluating the therapeutic response of chemoembolization for hepatocellular carcinoma (HCC).To assess the perfusion changes of HCC after transarterial chemoembolization, and to investigate the values ...
Lin, Yang +5 more
openaire +2 more sources
Computed tomographic (CT) perfusion imaging has been applied in many clinical areas, but few studies have addressed the values of CT perfusion imaging in evaluating the therapeutic response of chemoembolization for hepatocellular carcinoma (HCC).To assess the perfusion changes of HCC after transarterial chemoembolization, and to investigate the values ...
Lin, Yang +5 more
openaire +2 more sources
Radiology, 2023
Background Hepatocellular carcinomas (HCCs) can be divided into proliferative and nonproliferative types, which may have implications for outcomes after conventional transarterial chemoembolization (cTACE). Biopsy to identify proliferative HCC is not routinely performed before cTACE.
Yan Bao +9 more
openaire +2 more sources
Background Hepatocellular carcinomas (HCCs) can be divided into proliferative and nonproliferative types, which may have implications for outcomes after conventional transarterial chemoembolization (cTACE). Biopsy to identify proliferative HCC is not routinely performed before cTACE.
Yan Bao +9 more
openaire +2 more sources
Journal of Digestive Diseases, 2020
ObjectiveTransarterial chemoembolization (TACE) is the treatment modality for intermediate, or Barcelona Clinic Liver Cancer stage B, hepatocellular carcinoma (HCC), but its beneficial effect on outcomes is still unsatisfactory. This study aimed to assess the outcomes of combined TACE and sorafenib for patients with intermediate HCC.MethodsPatients ...
Shou Wu Lee +4 more
openaire +2 more sources
ObjectiveTransarterial chemoembolization (TACE) is the treatment modality for intermediate, or Barcelona Clinic Liver Cancer stage B, hepatocellular carcinoma (HCC), but its beneficial effect on outcomes is still unsatisfactory. This study aimed to assess the outcomes of combined TACE and sorafenib for patients with intermediate HCC.MethodsPatients ...
Shou Wu Lee +4 more
openaire +2 more sources
Hepatology Research, 2013
AimThe therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin was evaluated in comparison with that using epirubicin in patients with hepatocellular carcinoma (HCC).MethodsTwo hundred and eight‐nine HCC patients receiving TACE were retrospectively enrolled; none of the patients gave a previous TACE history.
Takahiro, Handa +9 more
openaire +2 more sources
AimThe therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin was evaluated in comparison with that using epirubicin in patients with hepatocellular carcinoma (HCC).MethodsTwo hundred and eight‐nine HCC patients receiving TACE were retrospectively enrolled; none of the patients gave a previous TACE history.
Takahiro, Handa +9 more
openaire +2 more sources
CardioVascular and Interventional Radiology, 2013
Magnetic resonance navigation (MRN), achieved with an upgraded MRI scanner, aims to guide new therapeutic magnetic microcarriers (TMMC) from their release in the hepatic vascular network to liver tumor. In this technical note, in vitro and in vivo MRI properties of TMMC, loaded with iron-cobalt nanoparticles and doxorubicin, are reported by following ...
Pierre, Pouponneau +4 more
openaire +3 more sources
Magnetic resonance navigation (MRN), achieved with an upgraded MRI scanner, aims to guide new therapeutic magnetic microcarriers (TMMC) from their release in the hepatic vascular network to liver tumor. In this technical note, in vitro and in vivo MRI properties of TMMC, loaded with iron-cobalt nanoparticles and doxorubicin, are reported by following ...
Pierre, Pouponneau +4 more
openaire +3 more sources
Oncology, 2013
Two randomized controlled trials identified that transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) shows a significant survival benefit compared with controls, after a long-term controversy. Thus, TACE is the current standard of care for patients presenting with multinodular HCC.
Yasunori, Minami, Masatoshi, Kudo
openaire +2 more sources
Two randomized controlled trials identified that transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) shows a significant survival benefit compared with controls, after a long-term controversy. Thus, TACE is the current standard of care for patients presenting with multinodular HCC.
Yasunori, Minami, Masatoshi, Kudo
openaire +2 more sources
Journal de radiologie, 2012
Chemoembolization of bone metastases is defined by the intraarterial perfusion of a chemotherapy agent followed by microparticles embolization to improve tissue impregnation. This technique increases the local concentration of the chemotherapy agent. Tumor response (stable or reduced tumor size) is achieved in 30-80% of cases with symptomatic relief in
F, Clarençon +6 more
openaire +1 more source
Chemoembolization of bone metastases is defined by the intraarterial perfusion of a chemotherapy agent followed by microparticles embolization to improve tissue impregnation. This technique increases the local concentration of the chemotherapy agent. Tumor response (stable or reduced tumor size) is achieved in 30-80% of cases with symptomatic relief in
F, Clarençon +6 more
openaire +1 more source
[Transarterial chemoembolization (TACE) of liver metastases. A palliative therapeutic approach].
Der Radiologe, 2001Metastatic involvement of the liver determines the treatment. Hepatic artery chemoembolization (TACE) represents a safe palliative treatment for patients with unresectable liver metastases. Technical treatment, indication and results of the TACE are reported.
S, Zangos +6 more
openaire +1 more source
[Recurrent hypoglycemia caused by malignant insulinoma: chemoembolization as a therapeutic option].
Medizinische Klinik (Munich, Germany : 1983), 2001A 73-year-old previously healthy woman presented with recurrent weakness, vertigo and perioral paresthesia of 3 months' duration. Physical examination on admission was unremarkable and revealed a patient in good condition.Recurrent episodes of fasting hypoglycemia let us to proceed with a fasting test.
M, Schütt +5 more
openaire +1 more source